PSTV

#4003
PLUS THERAPEUTICS, Inc. - Common Stock
5.8 2 USD
-9.49%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
5.82
5.82
Intervallo Annuale
0.13
8.00
Variazione giornaliera
-9.49%
Variazione Mensile
+4.49%
Variazione di 6 mesi
+854.10%
Variazione Annuale
+1906.90%
Chiusura Precedente
6.4 3
Open
5.8 2
Minimo
5.8 2
High
5.8 2
Volume
22
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 40.06 M
  • Employee 28
  • Founded 1996
  • CEO N/A
  • Website www.plustherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000C1Z086
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.77
Rapporto prezzo/fatturato
7.65

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Notizie